Mr. Thomas Lynch is Chairman of the board since January 2013.
Mr. Lynch has been a member of the board since August 1994 and has served as senior independent director from 2010 to 2012. Mr. Lynch has been a member of the Audit Committee since 1998 (Chairman 1998-2002 and 2008-2012) and as a member of the Compensation Committee (Chairman 2002-2008) and is Chairman of its Nominations and Governance Committee since February 2013.
Mr. Lynch served as Chairman and Chief Executive Officer of Amarin Corporation from December 2007 to December 2009, during which time he re-purposed and refinanced the company toward the development of Vascepa for hypertriglyceridemia and dislipidemia. Mr. Lynch retired from the Board of Amarin in October 2010 but continues as Chairman of Amarin Pharmaceuticals Ireland Ltd.
Mr. Lynch served in a variety of senior roles in Elan Corporation plc from 1993 to 2004. He was a director of IDA Ireland from 2001 to 2010 and of the Royal Opera House (Covent Garden) from 2001-2010. He currently serves as a director of GW Pharmaceuticals plc, is Chairman of Dublin Academic Medical Centre; and the Queens University of Belfast Foundation. He also serves as a board member of a number of public and privately held pharmaceutical companies.
Ciaran Murray is the Chief Executive Officer of ICON. He joined ICON as Chief Financial Officer in 2005, serving in that capacity until his appointment as Chief Executive. Prior to joining ICON, he held a number of senior financial positions in global organisations including Kraft Foods. Novell Inc. Northern Foods and Codec Systems.
He graduated with a Bachelor of Commerce degree from the University College Dublin and qualified as a Chartered Accountant with PwC
Dr. John Climax, one of ICON's co-founders, was Chairman from November 2002 to December 2009. Prior to that, from June 1990 to November 2002 he served as Chief Executive of the Company . He has over 25 years of experience in the contract research industry globally.
John received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his PhD in clinical pharmacology from the National University of Ireland in 1982.
He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland.
Dr. Lambe, one of the Company’s co-founders, served as Chairman of the Board of the Company from June 1990 to November 2002.
He has been a non executive director since January 2008. Dr. Lambe has over 30 years experience in the contract research industry. Dr. Lambe attended the National University of Ireland where he received his Bachelor of Science degree in chemistry in 1959, his masters in biochemistry in 1962 and his PhD. in pharmacology in 1976.
Professor Dermot Kelleher joined the ICON board as an independent director in May 2008.
Professor Kelleher is currently Principal at the Faculty of Medicine at Imperial College London and Dean of the Lee Kong Chian School of Medicine Singapore, a partnership between Imperial College London and Nanyang Technological University (NTU), which was formed in 2010. From 2004 to 2012 he was Head of the School of Medicine and Vice Provost for Medical Affairs at Trinity College, Dublin, Ireland. His research interests are broad ranging in the fields of Gastroenterology, Immunology and Molecular Biology and over a distinguished thirty year career he has led significant research projects in this field.
Alongside his notable academic appointments he has served as a visiting research scientist with a major pharmaceutical company and has been a founder of a number of biotechnology companies.
Declan McKeon was appointed as a non-executive director in April 2010
Mr. McKeon was a partner in PricewaterhouseCoopers (PwC) from 1986-2007. Declan's roles included leadership of the audit and business advisory team for PwC Ireland, membership on the PwC Europe audit and business advisory services executive and market sector lead for consumer and industrial products. Declan is a non-executive Director of Ryanair plc, he remains a consultant to PwC and sits on the audit committee of the Royal College of Surgeons in Ireland.
Declan holds a Bachelor of Commerce and Masters in Business Studies from University College Dublin and is a Fellow of The Institute of Chartered Accountants in Ireland.
Cathrin is a Special Partner at Vitruvian Partners LLP and is a Non Executive Director for Circassia Ltd. She is an advisor to the pharmaceutical industry and formerly served as a Non Executive Director for the NHS (Strategic Health Authority for Greater London),
Between 2000 and 2010 Cathrin was a Healthcare Partner in Apax Partners LLP with responsibility for originating, executing, monitoring and exiting healthcare private equity investments. Her early career included Senior Associate and Research Analyst roles at Schroder Ventures Life Sciences and Schroders Investment Management.
Professor William Hall joined the ICON board as an independent director in February 2013.
A renowned expert in infectious diseases and virology, Professor Hall is Chair of Medical Microbiology and Director of the Centre for Research in Infectious Diseases at University College Dublin’s (UCD) School of Medicine and Medical Science. He is also a director of UCD’s National Virus Reference Laboratory and is a consultant microbiologist at St. Vincent’s University Hospital Dublin. Professor Hall also serves as a consultant to the Minister of Heath and Children in the Republic of Ireland, providing input on a number of topics including influenza pandemic preparedness and bioterrorism.
Prior to his tenure at UCD, Professor Hall was Professor and Head of the Laboratory of Medical Virology, Senior Physician and Director of the Clinical Research Centre at the Rockefeller University in New York. He has also served as an Assistant and Associate Professor of Medicine at Cornell University.
Professor Hall is a board member of The Atlantic Philanthropies and is a co-founder of the Global Virus Network.
Diarmaid Cunningham is ICON's General Counsel. Diarmaid joined ICON as General Counsel in November 2009 having spent 10 years with A&L Goodbody which is one of Ireland's premier corporate law firms.
Diarmaid graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997 and qualified as a Solicitor with A&L Goodbody in 2001.